ZBAO · Zhibao Technology Inc. Class A Ordinary Shares

Zhibao Technology Inc. operates as a Cayman Islands holding company with all substantive business conducted through PRC subsidiaries, primarily Zhibao China and Sunshine Insurance Brokers, focusing on digital insurance brokerage via a pioneering 2B2C embedded model. This approach leverages partnerships with 2,400+ B channels (internet platforms, enterprises, government agencies) to embed customized insurance solutions into their customer ecosystems, reaching 24M end customers efficiently without heavy direct marketing spend. Revenue derives mainly from brokerage commissions (94-99% of total) and MGU fees, with FY2025 revenue surging 51% to RMB277M despite a RMB62M net loss amid expansion. The model benefits all parties: B channels gain value-added services, end customers get tailored products, and Zhibao secures low-cost customer acquisition while negotiating optimal policies with 100+ insurers.

Financially, growth is robust but profitability elusive; FY2024 marked breakeven with RMB13M profit before FY2025 losses from scaling. Accumulated deficits (RMB194M) and operating cash burn (RMB21M FY2025) raise going concern doubts, reliant on equity/debt raises like the $15M Hudson ELOC and $6.7M 3i Notes. This F-1 registers 23.8M Class A shares for 3i resale upon note conversion at $0.87 (discounted to market), with no proceeds to Zhibao—purely providing investor liquidity. Dual-class structure entrenches CEO Botao Ma's 93.8% voting control via 16.8M Class B shares (20x voting), designating Zhibao a Nasdaq 'controlled company' exempt from certain governance rules.

PRC regulatory overlay dominates risks: mandatory CSRC filing within 3 days post-effectiveness under New Overseas Listing Rules for follow-on offerings; prior cybersecurity review cleared for IPO but data handling (24M users) invites CAC scrutiny. Dividend repatriation hurdles, forex controls, and PCAOB access issues threaten delisting under HFCA (now 2-year trigger). Acquisitions like 51% Zhonglian (RMB25.5M) and Zhibao Yingshi JV expand footprint but expose execution risks. Management's insurance/tech pedigrees (CEO's 30+ years) support innovation, but concentrated control and China-centric ops amplify geopolitical/tax risks (potential 10% withholding on dividends). Investors face high volatility from small float, insider dominance, and regulatory flux, with no dividend plans—returns hinge on growth execution amid uncertain U.S.-China dynamics.